Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-10-24

Clinical Trial Update: Quetiapine Induced Neuroplasticity in First-episode Schizophrenic Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating quetiapine's effects on neuroplasticity in patients with first-episode schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine (quetiapine)

Snippet

Sponsor: University of Regensburg | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED